
BPC-157 (Body Protection Compound)
Stable 15-amino acid research pentadecapeptide investigated in cytoprotection models.

Selective pentapeptide growth hormone secretagogue receptor (GHSR-1a) agonist.
Laboratory Research Disclaimer: This chemical compound is sold strictly for analytical, in vitro, and laboratory research investigations. Not approved for human or veterinary administration.
Certified analytical research vials in 6 verified packaging specifications. Direct B2B batch allocation available.
| Cat. No | Configuration / Name | Packaging Spec | Purity / QC | Stock Status | Actions |
|---|---|---|---|---|---|
| BPC-157-PENTADECAPEPTIDE | BPC-157 (Body Protection Compound) | Lyophilized Powder, Sterile Sealed Vial | ???99.0% (HPLC) | In Stock (-20°C) | |
| CJC-1295-DAC | CJC-1295 with DAC | Lyophilized Powder, Sterile Sealed Vial | ???98.0% (HPLC) | In Stock (-20°C) | |
| IPAMORELIN-STANDARD | Ipamorelin (Selective GH Secretagogue)Current Selection | Lyophilized Powder, Sterile Sealed Vial | ???98.5% (HPLC) | In Stock (-20°C) | |
| IP10 | Ipamorelin 10mg*10vials (IP10) | 10mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| IP5 | Ipamorelin 5mg*10vials (IP5) | 5mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TI15 | Tesamorelin 10mg+Ipamorelin 5mg 15mg*10vials (TI15) | 15mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) |
Synthetic pentapeptide exhibiting selective growth hormone secretagogue receptor stimulation without concomitant stimulation of ACTH, cortisol, or prolactin in preclinical models.
Reconstitution & Stability Guidance: Lyophilized peptides should be equilibrated to room temperature before reconstitution. Spin vial gently to ensure all powder is at the bottom. Reconstitute using sterile bacteriostatic or deionized water according to your experimental protocol. Reconstituted solutions should be aliquoted to avoid repeated freeze-thaw cycles and maintained at -20°C or below.

Stable 15-amino acid research pentadecapeptide investigated in cytoprotection models.

Synthetic GHRH analogue conjugated to Drug Affinity Complex (DAC) for prolonged bioconjugation studies.